Proactive Investors Australia | Cellmid awarded key European midkine antibodies patent, covers cancer and ... Proactive Investors Australia Maria Halasz, Cellmid's chief executive officer, commented: “Having patents granted in Europe for our MK antibodies across such a wide array of diseases is a tremendous commercial outcome for Cellmid. “This patent gives Cellmid very clear exclusive ... |
